- Home
- ITRM vs REVG Comparison
ITRM vs REVG Comparison
Compare ITRM & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- REVG
- Stock Information
- Founded
- ITRM 2015
- REVG 2008
- Country
- ITRM Ireland
- REVG United States
- Employees
- ITRM N/A
- REVG N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- REVG Auto Manufacturing
- Sector
- ITRM Health Care
- REVG Consumer Discretionary
- Exchange
- ITRM Nasdaq
- REVG Nasdaq
- Market Cap
- ITRM 40.0M
- REVG 2.2B
- IPO Year
- ITRM 2018
- REVG 2017
- Fundamental
- Price
- ITRM $1.16
- REVG $48.56
- Analyst Decision
- ITRM Strong Buy
- REVG Hold
- Analyst Count
- ITRM 2
- REVG 4
- Target Price
- ITRM $7.00
- REVG $41.25
- AVG Volume (30 Days)
- ITRM 612.5K
- REVG 701.8K
- Earning Date
- ITRM 08-13-2025
- REVG 09-03-2025
- Dividend Yield
- ITRM N/A
- REVG 0.49%
- EPS Growth
- ITRM N/A
- REVG N/A
- EPS
- ITRM N/A
- REVG 1.86
- Revenue
- ITRM N/A
- REVG $2,331,500,000.00
- Revenue This Year
- ITRM N/A
- REVG $3.60
- Revenue Next Year
- ITRM $270.19
- REVG $6.89
- P/E Ratio
- ITRM N/A
- REVG $26.04
- Revenue Growth
- ITRM N/A
- REVG N/A
- 52 Week Low
- ITRM $0.81
- REVG $21.54
- 52 Week High
- ITRM $3.02
- REVG $50.34
- Technical
- Relative Strength Index (RSI)
- ITRM 61.00
- REVG 65.57
- Support Level
- ITRM $0.91
- REVG $48.03
- Resistance Level
- ITRM $1.03
- REVG $50.34
- Average True Range (ATR)
- ITRM 0.05
- REVG 1.23
- MACD
- ITRM 0.01
- REVG -0.11
- Stochastic Oscillator
- ITRM 95.18
- REVG 72.02
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.